Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II

Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II

Saved in:

Bibliographic Details
Main Authors:	Kevin A. Henry, Greg Hussack, Jan Gettemans, Cory L. Brooks
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	single-domain antibody nanobody VHH VNAR antibody engineering antibody therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1537054/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Distinct types of VHHs in Alpaca
by: Xinhao Wang, et al.
Published: (2024-11-01)

Neutralizing VHH Antibodies Targeting the Spike Protein of PEDV
by: Li Zhang, et al.
Published: (2024-11-01)

Redirecting a Broad-Spectrum Nanobody Against the Receptor-Binding Domain of SARS-CoV-2 to Target Omicron Variants
by: Kwanpet Intasurat, et al.
Published: (2024-11-01)

Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
by: Christine N. Vuong, et al.
Published: (2024-12-01)

Nanobody-as versatile tool emerging in autoimmune diseases
by: Ling Wang, et al.
Published: (2024-12-01)

Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
by: Apisitt Thaiprayoon, et al.
Published: (2025-01-01)

Expression Analysis of Heavy-Chain-Only Antibodies in Cloudy Catshark and Japanese Bullhead Shark
by: Reo Uemura, et al.
Published: (2025-01-01)

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
by: Scott McComb, et al.
Published: (2024-03-01)

A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses
by: Qinglin Kang, et al.
Published: (2024-12-01)

Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration
by: Paul Tamburini, et al.
Published: (2024-12-01)

Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt
by: Aubin Ramon, et al.
Published: (2025-12-01)

Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
by: Rebecca Faresjö, et al.
Published: (2024-12-01)

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
by: Jonatan Dewulf, et al.
Published: (2024-12-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Exploiting SUMO Fusion Technology for Enhanced Expression of Nanobodies Targeting Vascular Endothelial Growth Factor (VEGF) in Escherichia coli
by: Salim Alhafyan
Published: (2024-10-01)

The potential role of nanobodies in asthma therapy
by: Baraa Khalid Salah Al-Sheakly, et al.
Published: (2025-01-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies
by: Gregor Rossmueller, et al.
Published: (2024-12-01)

The Application of Machine Learning on Antibody Discovery and Optimization
by: Jiayao Zheng, et al.
Published: (2024-12-01)

Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?
by: Paul James Patrick Martin, et al.
Published: (2024-11-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

The EV antibody database: An interactive database of curated antibodies for extracellular vesicle and nanoparticle research
by: Amber Morey, et al.
Published: (2024-06-01)

Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation
by: Lujia Sun, et al.
Published: (2024-01-01)

Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors
by: Li TT, et al.
Published: (2024-11-01)

Do antibody CDR loops change conformation upon binding?
by: Chu’nan Liu, et al.
Published: (2024-12-01)

Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies
by: Nuchjira Takheaw, et al.
Published: (2024-11-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations
by: Zirui Zhu, et al.
Published: (2024-12-01)

Antiplatelet antibodies in patients with ITP and patient with platelet refractoriness
by: Salah Aref, et al.
Published: (2014-08-01)

Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01)

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
by: Zhihong Wang, et al.
Published: (2024-12-01)

High-throughput single-cell screening of viable hybridomas and patient-derived antibody-secreting cells using punchable microwells
by: Kaat Rubben, et al.
Published: (2024-12-01)

Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024-11-01)

TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models
by: Yang Shi, et al.
Published: (2024-12-01)

Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant
by: Lauren A. Ford-Siltz, et al.
Published: (2024-12-01)

Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function
by: Tanusya Murali Murali, et al.
Published: (2024-12-01)

Association of Anti-Thyroglobulin and Anti-Thyroid Peroxidase Antibodies in Patients with Primary Hypothyroidism
by: Taghreed S. Saeed Al-Rawi, et al.
Published: (2023-12-01)

Antibody characterization is critical to enhance reproducibility in biomedical research
by: Richard A Kahn, et al.
Published: (2024-08-01)